FDA Approves Otulfi™, a Biosimilar to Stelara®
September 30, 2024
FDA Approves Otulfi™, a Biosimilar to Stelara®
September 30, 2024

GENERIC DRUG APPROVALS


September 2024

Drospirenone Tablets 4mg
Approved: September 30, 2024 - Lupin Ltd.
Indicated for: Contraception
Generic for: Slynd

Related posts

September 30, 2024

FDA Approves Otulfi™, a Biosimilar to Stelara®

Read more
September 27, 2024

FDA Approves Flyrcado Radioactive Diagnostic for Enhanced Diagnosis of CoronaryArtery Disease

Read more
September 26, 2024

FDA is Alerting Patients and Health Care Professionals About the Voluntary Withdrawal of Oxbryta from the Market Due to Safety Concerns

Read more